|MDACC Study No:||2012-0178 (clinicaltrials.gov NCT No: NCT01358331)|
|Title:||A Phase I Study to Evaluate the Safety, Tolerability and Effectiveness of MK-8353 (formerly SCH 900353)in Subjects with Advanced Tumors|
|Principal Investigator:||Wen-Jen Hwu|
|Study Description:||The goal of this clinical research study is to learn if MK-8353 can help to |
control colorectal cancer and/or melanoma.
MK-8353 is designed to control an enzyme. If this enzyme is controlled, it may
help stop the growth of cancer cells.
There may be reasons why you are not allowed to take part in this study. The
study doctor or staff will discuss these with you.